Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel biphenyl derivative as well as preparation method and medical application thereof

A pharmaceutical, phenyl technology, applied in the field of tumor treatment, biphenyl derivatives, to achieve the effect of inhibiting binding, excellent activity, and good affinity

Active Publication Date: 2021-10-01
XIAN XINTONG PHARM RES CO LTD
View PDF23 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no small molecule inhibitor of PD-1 / PD-L1 on the market, so the development of small molecule inhibitors of PD-1 / PD-L1 has great practical significance and potential application prospects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel biphenyl derivative as well as preparation method and medical application thereof
  • Novel biphenyl derivative as well as preparation method and medical application thereof
  • Novel biphenyl derivative as well as preparation method and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] (4-((3'-(3-(4-(((1-carboxy-2-hydroxyethyl)amino)methyl)-1H-1,2,3-triazol-1-yl)propane Oxy)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)methoxy)-5-chloro-2-((5-cyanopyridin-3-yl) Methoxy)benzyl)serine (II-1:R 1 and R 2 for R 3 and R 4 for -CH 3 , R 5 for Cl, R 6 for n=3) Synthesis

[0074] Synthesis of 3-bromo-2-methylphenol (IV-1)

[0075] Add 3-bromo-2-methylaniline (5.00g, 26.9mmol) into the three-necked flask, slowly drop into sulfuric acid solution (65mL, 1mmol / L) while stirring, and a large amount of insoluble white solids precipitate out. After dropping, lower the internal temperature of the reaction solution to 0-5°C, slowly add 30% sodium nitrite solution (2.23g, 32.3mmol) dropwise, yellow insoluble matter is formed, after dropping, lower the temperature to 0-5°C and stir for 30 minute. Toluene (30 mL) was added, and the temperature was raised to 100° C. to react for 1 hour. Stop the reaction after the reaction solution is clear and transparent, cool to ro...

Embodiment 2

[0113] 5-((4-chloro-2-(((2-hydroxyethyl)amino)methyl)-5-((3'-(3-(4-(((2-hydroxyethyl)amino)methyl Base)-1H-1,2,3-triazol-1-yl)propoxy)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)methoxy ) phenoxy) methyl) nicotinonitrile (II-2: R 1 and R 2 for R 3 and R 4 for -CH 3 , R 5 for Cl, R 6 for n=3) Synthesis

[0114] Dissolve compound XVI-1 (0.20g, 0.31mmol) and ethanolamine (57μL, 0.95mmol) in a mixed solution of dichloromethane (4mL) and methanol (2mL), stir at room temperature for 30min, and slowly add NaBH(OAc) 3 (0.81g, 3.80mmol), react at room temperature for 2 hours. TLC monitors that the reaction of raw materials is complete, and the reaction is stopped. Adjust the pH to 7 with saturated sodium bicarbonate solution, extract with dichloromethane (10mL×2), combine the organic phases, wash with water (10mL×2) and saturated sodium chloride solution (10mL×2), and anhydrous sodium sulfate Dry, filter with suction, and remove the solvent under reduced pressure to obtain a ligh...

Embodiment 3

[0117] N-(2-((4-((3'-(3-(4-(((2-acetylaminoethyl)amino)methyl)-1H-1,2,3-triazole-1- base)propoxy)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)methoxy)-5-chloro-2-((5-cyanopyridine-3 -yl) methoxy) benzyl) amino) ethyl) acetamide (II-3: R 1 and R 2 for R 3 and R 4 for -CH 3 , R 5 for Cl, R 6 for n=3) Synthesis

[0118] Compound XVI-1 (0.20g, 0.31mmol) and N-acetylethylenediamine (0.10g, 0.95mmol) were dissolved in dichloromethane (5mL) and added to the reaction flask successively, stirred at room temperature for 30min, and NaBH(OAc ) 3 (0.81g, 3.80mmol), react at room temperature for 2 hours. TLC monitors that the reaction of raw materials is complete, and the reaction is stopped. Adjust the pH to 7 with saturated sodium bicarbonate solution, extract with dichloromethane (10 mL×2), combine the organic phases, wash with water (10 mL×2) and saturated sodium chloride (10 mL×2), and dry over anhydrous sodium sulfate. Suction filtration, the solvent was removed under reduced pr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicinal chemistry, and discloses a biphenyl derivative with PD-1 / PD-L1 inhibitory activity as well as a preparation method and application thereof. The invention further discloses a composition containing the biphenyl derivative with the PD-1 / PD-L1 inhibitory activity or the pharmaceutically acceptable salt of the biphenyl derivative and a pharmaceutically acceptable carrier of the biphenyl derivative, and an application of the composition in preparation of a PD-1 / PD-L1 inhibitor. The compound can be used for treating tumors.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and specifically relates to a class of biphenyl derivatives with PD-1 / PD-L1 inhibitory activity, a preparation method, a pharmaceutical composition containing these compounds and their use in treating tumors. [0002] technical background [0003] In recent years, tumor immunotherapy has become the focus in the field of tumor treatment. Unlike traditional treatments that directly target tumor cells, tumor immunotherapy uses the body's own immune system to kill tumor cells. The activation of the immune checkpoint pathway will inhibit the activation of T cells, prevent the excessive activation of the human immune system, maintain the immune tolerance of the normal body, and avoid the occurrence of autoimmune diseases. Tumors lead to tumor immune escape by overactivating immune checkpoint pathways by themselves and some lymphocytes. Among these immune checkpoints, the overactivation of PD-1 / PD-L1 ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/12C07D401/14C07D403/14C07D249/04A61K31/4439A61K31/4545A61K31/4192A61P35/00
CPCC07D401/12C07D401/14C07D403/14C07D249/04A61P35/00
Inventor 徐云根张宏波朱启华杜慧杰夏宇于春秋黄诗卉李慧邹毅
Owner XIAN XINTONG PHARM RES CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com